Roivant Sciences (ROIV): Chief Accounting Officer sold ~$384K
Jennifer Humes, Chief Accounting Officer at Roivant Sciences, sold ~$384K of Roivant Sciences shares.
- ~$384K
- Approx. value · 14K sh @ $28.37
- 84K
- Holds after · shares reported
- Traded
- Apr 8, 2026
- Filed
- Apr 11, 2026
What stands out in this filing
- The sale was 13.9% of the shares this insider held before it; the filing reports 84,191 shares afterwards.
- 13,538 shares at an average of $28.37 each, as reported on the form.
- No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 9, 2026InsiderDirector sold ~$8.99M of ROIV shares in the open market
- Feb 11, 2026Insider · 3 peopleInsiders: 3 sales (~$34.0M)
- Feb 12, 2026Insider · 3 peopleInsiders: 6 sales (~$34.1M)
- Feb 13, 2026Insider · 4 peopleInsiders: 7 sales (~$35.2M)
- Feb 19, 2026InsiderChair sold ~$38.4M of ROIV shares in the open market
- Feb 20, 2026InsiderChair sold ~$27.5M of ROIV shares in the open market
- Feb 23, 2026InsiderChair sold ~$16.2M of ROIV shares in the open market
- Mar 3, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
- Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Mar 16, 2026InsiderDirector sold ~$1.2M of ROIV shares in the open market
- Mar 17, 2026InsiderCEO sold ~$5.65M of ROIV shares in the open market
- Mar 26, 2026Insider · 7 days before resultsDirector sold ~$1.92M of ROIV shares in the open market
- Apr 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Apr 8, 2026 · this disclosureInsiderOfficer sold ~$384K of ROIV shares in the open market
What came next
- Apr 16, 2026InsiderCEO sold ~$8.45M of ROIV shares in the open market
- Apr 20, 2026InsiderCEO sold ~$5.92M of ROIV shares in the open market
- May 20, 2026Company filing · Form 8-K · ResultsReported its results
- May 22, 2026InsiderCEO sold ~$6.05M of ROIV shares in the open market
- Jun 24, 2026Insider · 1 personInsiders: 2 sales (~$6.6M)
- Jun 25, 2026InsiderDirector sold ~$17.1M of ROIV shares in the open market
- Jun 26, 2026Insider · 4 peopleInsiders: 7 sales (~$80.9M)
- Jun 29, 2026Insider · 4 peopleInsiders: 8 sales (~$83.5M)
- Jun 30, 2026Insider · 4 peopleInsiders: 5 sales (~$8.7M)
- Jul 27, 2026InsiderCEO sold ~$6.99M of ROIV shares in the open market
- Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Roivant Sciences
For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.
How this filing works
Explore the data
Common questions
Which Roivant Sciences (ROIV) insider traded, and how much?
Jennifer Humes, Chief Accounting Officer at Roivant Sciences, sold ~$384K of Roivant Sciences shares. 14K shares at $28.37.
When did it happen, and when was it made public?
Traded: Apr 8, 2026. Filed: Apr 11, 2026. That is 3 days between the two dates.
What stands out in this filing?
The sale was 13.9% of the shares this insider held before it; the filing reports 84,191 shares afterwards. 13,538 shares at an average of $28.37 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Roivant Sciences recently?
For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ROIV page.
Does this mean ROIV stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Roivant Sciences
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
Everything OQRO holds on this company is on its ROIV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
